And here is is auto respond bulls**t response:
Dear Follower of Galectin Therapeutics,
Thank you for commenting on “CEO Perspectives”. Your views and questions are important to me, so please keep them coming. While I will not be answering each comment with an individual email, your comments will be used for informing topics and explanations in future “CEO Perspectives” posts. In this way, the broader market of interested investors will benefit from your comments. Thank you for your interest in Galectin Therapeutics.
All the best,
Peter G. Traber, MD
President, CEO, and CMO
Galectin Therapeutics